| Status | Study |
| Recruiting |
Study Name: Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites Condition: Liver Cirrhoses Date: 2017-05-27 Interventions: Procedure: TIPS Transjugular i |
| Not yet recruiting |
Study Name: Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites Condition: Cirrhosis Ascites Peritonitis Date: 2017-02-27 Interventions: Drug: Rifaximin twice daily ad |
| Not yet recruiting |
Study Name: Chyle Leak After Pancreatic Surgery Condition: Postoperative Chyle Leak Date: 2017-02-25 Interventions: Other: Standard care irrespective of CL |
| Recruiting |
Study Name: A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites Condition: Malignant Ascites Apatinib Date: 2017-01-10 Interventions: Drug: Apatinib Patients will take 500mg apatinib daily orally. |
| Completed |
Study Name: Acute Hemodynamic Changes During Paracentesis Condition: Tense Ascites Liver Cirrhosis Date: 2016-12-14 Interventions: Procedure: routine therapeutic paracentesis |
| Active, not recruiting |
Study Name: PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis Condition: Cirrhosis Ascites Hepatic Date: 2016-12-13 Interventions: Device: PleurX, peritoneal tunnelated catheter |
| Recruiting |
Study Name: Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites Condition: Liver Cirrhosis Ascites Date: 2016-11-22 Interventions: Device: Peritoneal Dialysis Catheter |
| Not yet recruiting |
Study Name: Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites Condition: Cirrhosis Ascites Hepatic Date: 2016-11-20 Interventions: Drug: Terlipressin acetate continuous infusion Low-dose continuous infusion of Terlipressin administered |
| Recruiting |
Study Name: G-CSF Plus NAC In Severe Alcoholic Hepatitis Condition: Alcoholic Hepatitis Date: 2016-11-09 Interventions: Drug: standard medical therapy |
| Completed |
Study Name: Retrospective Analysis of Patients Treated With Bevacizumab in GHPSJ Intraperitoneal for the Treatment of Refractory Malignant Ascites Condition: Refractory Malignant Ascites Date: 2016-09-01 Interventions: Other: No intervention. Descriptive study |